{"entity":{"type":"insider","cik":"0001898147","url":"/insider/0001898147","json_url":"/insider/0001898147.json","name":"Poradosu Enrique","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2022-02-08","last":"2024-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Poradosu Enrique","source":"filing","n_filings":5,"first_seen":"2022-02-08","last_seen":"2024-11-20"}],"transactions":[{"id":3268794,"accession":"0001104659-24-120876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-120876","line_url":"/filing/0001104659-24-120876#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001898147","owner_name":"Poradosu Enrique","owner_display_name":"Poradosu Enrique","owner_url":"/insider/0001898147","role":"Officer (Chief Science & Business Off)","role_mark":"O","role_mark_label":"Officer (Chief Science & Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Business Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":9980.0,"total_display":"9,980.00","total_whole":"9,980","shares_owned_after":1506319.0,"shares_owned_after_display":"1,506,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-20","scope":"insider"},{"id":2212966,"accession":"0001104659-24-060262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-060262","line_url":"/filing/0001104659-24-060262#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001898147","owner_name":"Poradosu Enrique","owner_display_name":"Poradosu Enrique","owner_url":"/insider/0001898147","role":"Officer (Chief Science & Business Off)","role_mark":"O","role_mark_label":"Officer (Chief Science & Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Business Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":3145.0,"total_display":"3,145.00","total_whole":"3,145","shares_owned_after":1504319.0,"shares_owned_after_display":"1,504,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-13","scope":"insider"},{"id":8697282,"accession":"0001104659-23-037421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-037421","line_url":"/filing/0001104659-23-037421#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001898147","owner_name":"Poradosu Enrique","owner_display_name":"Poradosu Enrique","owner_url":"/insider/0001898147","role":"Officer (Chief Science & Business Off)","role_mark":"O","role_mark_label":"Officer (Chief Science & Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Business Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":11.55,"price_display":"11.55","price_state":"stated","total_value":5775.0,"total_display":"5,775.00","total_whole":"5,775","shares_owned_after":1373819.0,"shares_owned_after_display":"1,373,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-28","scope":"insider"},{"id":6648543,"accession":"0001104659-22-060908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-060908","line_url":"/filing/0001104659-22-060908","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001898147","owner_name":"Poradosu Enrique","owner_display_name":"Poradosu Enrique","owner_url":"/insider/0001898147","role":"Officer (Chief Science & Business Off)","role_mark":"O","role_mark_label":"Officer (Chief Science & Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Business Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":670.0,"shares_display":"670","price_per_share":15.33313432835821,"price_display":"15.33","price_state":"stated","total_value":10273.2,"total_display":"10,273.20","total_whole":"10,273","shares_owned_after":1258019.0,"shares_owned_after_display":"1,258,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider","n_lines":2},{"id":6990341,"accession":"0001104659-22-014376","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-014376","line_url":"/filing/0001104659-22-014376#line-2","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001898147","owner_name":"Poradosu Enrique","owner_display_name":"Poradosu Enrique","owner_url":"/insider/0001898147","role":"Officer (Chief Science & Business Off)","role_mark":"O","role_mark_label":"Officer (Chief Science & Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Business Off","security_title":"Common Stock, par value $0.00001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":3.88,"price_display":"3.88","price_state":"stated","total_value":3104.0,"total_display":"3,104.00","total_whole":"3,104","shares_owned_after":1197649.0,"shares_owned_after_display":"1,197,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-08","scope":"insider"},{"id":6990339,"accession":"0001104659-22-014376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-014376","line_url":"/filing/0001104659-22-014376#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001898147","owner_name":"Poradosu Enrique","owner_display_name":"Poradosu Enrique","owner_url":"/insider/0001898147","role":"Officer (Chief Science & Business Off)","role_mark":"O","role_mark_label":"Officer (Chief Science & Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Business Off","security_title":"Common Stock, par value $0.00001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800.0,"shares_display":"3,800","price_per_share":3.35,"price_display":"3.35","price_state":"stated","total_value":12730.0,"total_display":"12,730.00","total_whole":"12,730","shares_owned_after":1196849.0,"shares_owned_after_display":"1,196,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-04","filed_date":"2022-02-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001875558","name":"Nuvectis Pharma, Inc.","url":"/issuer/0001875558","role":"Officer (Chief Science & Business Off)","n_filings":5,"first_seen":"2022-02-08","last_seen":"2024-11-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001898147","retrieved_at":"2026-08-22T09:19:27+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}